Chicago, IL, United States of America

Joseph F Foss

This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Arch Development Corporation, Ur Labs, Inc., Other. Active years: 1999-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joseph F Foss. Retrieved from https://idiyas.com/inventor/joseph-f-foss

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 310(Granted Patents)


Company Filing History:

goldMedal1 out of 349 
 
Arch Development Corporation
 patents
silverMedal1 out of 2 
 
Ur Labs, Inc.
 patents
bronzeMedal3 out of 834,570 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2003

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Joseph F Foss: Innovator in Opioid Treatment

Introduction

Joseph F Foss is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of medicine, particularly in the treatment of opioid-induced side effects. With a total of 4 patents to his name, Foss has focused on innovative methods to improve patient care.

Latest Patents

Foss's latest patents include groundbreaking methods for preventing or treating opioid-induced changes in gastrointestinal motility. One of his notable inventions involves the use of methylnaltrexone or related compounds. This method comprises administering methylnaltrexone or another quaternary derivative of noroxymorphone to a patient prior to the administration of an opioid or after the onset of side effects induced by the administration of an opioid. The administration is done orally in an enterically coated form. Another significant patent addresses the treatment of chronic opioid use side effects. This method involves administering a quaternary derivative of noroxymorphone in an amount sufficient to prevent or treat the side effect in a patient who has been chronically taking opioids.

Career Highlights

Throughout his career, Foss has worked with various organizations, including Arch Development Corporation. His work has been instrumental in advancing the understanding and treatment of opioid-related issues.

Collaborations

Foss has collaborated with notable individuals in his field, including Michael F Roizen and Jonathan Moss. Their combined expertise has contributed to the development of effective treatment methods.

Conclusion

Joseph F Foss stands out as an innovator dedicated to improving the lives of patients dealing with the challenges of opioid use. His patents reflect a commitment to advancing medical science and enhancing patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…